{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:59:49Z","timestamp":1776070789306,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.schres.2014.04.028","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T12:46:27Z","timestamp":1400589987000},"page":"254-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia"],"prefix":"10.1016","volume":"156","author":[{"given":"Rodrigo","family":"Ferretjans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvina Maria","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ribeiro-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Carneiro","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keliane","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cec\u00edlia Alves","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio Sobreira","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o V.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2014.04.028_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2014.04.028_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.schres.2014.04.028_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"Mini International Neuropsychiatric Interview (MINI): valida\u00e7\u00e3o de entrevista breve para diagn\u00f3stico de transtornos mentais","volume":"22","author":"Amorim","year":"2000","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"4 Suppl.","key":"10.1016\/j.schres.2014.04.028_bb0020","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.5694\/j.1326-5377.2009.tb02371.x","article-title":"Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders","volume":"190","author":"Banati","year":"2009","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.schres.2014.04.028_bb0030","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","article-title":"The endocannabinoid system in normal and pathological brain ageing","volume":"367","author":"Bilkei-Gorzo","year":"2012","journal-title":"Philos. Trans. R. Soc. B"},{"issue":"13","key":"10.1016\/j.schres.2014.04.028_bb0035","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2014.04.028_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/glia.22372","article-title":"Microglia as modulators of cognition and neuropsychiatric disorders","volume":"61","author":"Blank","year":"2013","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/09540260902782760","article-title":"Basic neuroanatomy and neuropharmacology of cannabinoids","volume":"21","author":"Breivogel","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.04.028_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00029-2","article-title":"Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia","volume":"32","author":"Bressan","year":"1998","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.schres.2014.04.028_bb0065","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2174\/138161208785740018","article-title":"The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases","volume":"14","author":"Centonze","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.schres.2014.04.028_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.b.30592","article-title":"Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia","volume":"147","author":"Chavarr\u00eda-Siles","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"5","key":"10.1016\/j.schres.2014.04.028_bb0075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/00048670801961156","article-title":"Cannabis, cannabinoids and schizophrenia: integration of the evidence","volume":"42","author":"Cohen","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2014.04.028_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13546805.2012.730995","article-title":"How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS","volume":"18","author":"Cruz","year":"2013","journal-title":"Cogn. Neuropsychiatry"},{"issue":"8","key":"10.1016\/j.schres.2014.04.028_bb0085","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2011.43","article-title":"Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex","volume":"36","author":"Dalton","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2014.04.028_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: physiology and pharmacology","volume":"40","author":"de Fonseca","year":"2005","journal-title":"Alcohol Alcohol."},{"issue":"5","key":"10.1016\/j.schres.2014.04.028_bb0095","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis."},{"issue":"6830","key":"10.1016\/j.schres.2014.04.028_bb0100","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.schres.2014.04.028_bb0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archpsyc.64.5.532","article-title":"Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia","volume":"64","author":"Dickinson","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2014.04.028_bb0110","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2014.04.028_bb0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-009-1612-6","article-title":"Role of cannabis and endocannabinoids in the genesis of schizophrenia","volume":"206","author":"Fernandez-Espejo","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.schres.2014.04.028_bb0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S0047-20852010000400002","article-title":"Vers\u00e3o brasileira da Escala de Avalia\u00e7\u00e3o da Cogni\u00e7\u00e3o em Esquizofrenia (SCoRS-Br) - Valida\u00e7\u00e3o em contextos cl\u00ednicos sem informantes","volume":"59","author":"Ferreira","year":"2010","journal-title":"J. Bras. Psiquiatr."},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2014.04.028_bb0125","first-page":"S163","article-title":"The endocannabinoid system and its role in schizophrenia: a systematic review of the literature","volume":"34","author":"Ferretjans","year":"2012","journal-title":"RBP Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2014.04.028_bb0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/156800705774933069","article-title":"Endocannabinoids in the central nervous system: from neuronal networks to behavior","volume":"4","author":"Fride","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.schres.2014.04.028_bb0135","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2014.04.028_bb0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","article-title":"Lymphocytes as a neural probe: potential for studying psychiatric disorders","volume":"28","author":"Gladkevich","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.04.028_bb0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u201cright stuff\u201d?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2014.04.028_bb0150","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised. Psychopharmacology Research Branch, NIMH. DHEW Pub. No (ADM) 76-338, Rockville","first-page":"534","article-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Guy","year":"1976"},{"issue":"11","key":"10.1016\/j.schres.2014.04.028_bb0155","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.schres.2014.04.028_bb0160","series-title":"IBM SPSS Statistics for Windows","author":"IBM Corp","year":"2011"},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1073\/pnas.98.2.625","article-title":"A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes","volume":"98","author":"Ilani","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.schres.2014.04.028_bb0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.04.028_bb0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2014.04.028_bb0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1176\/appi.ajp.163.3.426","article-title":"The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity","volume":"163","author":"Keefe","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2014.04.028_bb0195","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00702-007-0660-5","article-title":"Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression","volume":"114","author":"Koethe","year":"2007","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.schres.2014.04.028_bb0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","article-title":"Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis","volume":"194","author":"Koethe","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2014.04.028_bb0205","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","article-title":"Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis","volume":"36","author":"Koskinen","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2014.04.028_bb0210","article-title":"Escalas de Avalia\u00e7\u00e3o de Efeitos Colaterais de Antipsic\u00f3ticos","volume":"25","author":"Louz\u00e3 Neto","year":"1998","journal-title":"Rev. Psiquiatr. Cl\u00edn."},{"issue":"23","key":"10.1016\/j.schres.2014.04.028_bb0215","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2174\/138161208785740135","article-title":"Expression and function of the endocannabinoid system in glial cells","volume":"14","author":"Massi","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.schres.2014.04.028_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2014.04.028_bb0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000100778","article-title":"Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain","volume":"54","author":"Onaivi","year":"2006","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1016\/j.schres.2014.04.028_bb0235","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2014.04.028_bb0240","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11065-009-9109-y","article-title":"What do we know about neuropsychological aspects of schizophrenia?","volume":"19","author":"Palmer","year":"2009","journal-title":"Neuropsychol. Rev."},{"issue":"46","key":"10.1016\/j.schres.2014.04.028_bb0245","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","article-title":"Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/157015912800604515","article-title":"Cannabinoid modulation of neuroinflammatory disorders","volume":"10","author":"Saito","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.schres.2014.04.028_bb0255","unstructured":"Salgado, J.V., 2008. Neuropsicologia da esquizofrenia, in: Fuentes, D., Malloy-Diniz, L.F., Camargo, C.H.P., Cosenza, R.M., organizadores, Neuropsicologia: Teoria e Pr\u00e1tica. Artmed Editora, Porto Alegre, pp. 273\u2013287."},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0260","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09540260902782802","article-title":"Cannabinoids and psychosis","volume":"21","author":"Sewell","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.schres.2014.04.028_bb0265","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2014.04.028_bb0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"1","key":"10.1016\/j.schres.2014.04.028_bb0275","first-page":"30","article-title":"Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?","volume":"32","author":"Solowij","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2014.04.028_bb0280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1590\/S0100-879X2003000400014","article-title":"Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients","volume":"36","author":"Tonelli","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.schres.2014.04.028_bb0285","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/15622970903414188","article-title":"Ultrastructural damage of capillaries in the neocortex in schizophrenia","volume":"11","author":"Uranova","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"5746","key":"10.1016\/j.schres.2014.04.028_bb0290","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"issue":"1\u20133","key":"10.1016\/j.schres.2014.04.028_bb0295","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.schres.2013.02.035","article-title":"Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care","volume":"146","author":"Vita","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2014.04.028_bb0300","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641400200X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641400200X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T16:53:27Z","timestamp":1565456007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641400200X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":57,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S092099641400200X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2014.04.028","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2014.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}